Is Biotech Facing a Rally?

“Price gouging like this in the specialty drug market is outrageous.  Tomorrow I’ll lay out a plan to take it on…” That’s what Democratic presidential candidate Hillary Clinton just tweeted. The 91-character tweet was enough to cripple biotech stocks.  The NASDAQ Biotech Index (NBI) – up 250% in three years – dropped 150 points minutes…